Altea Therapeutics alteatherapeutics.com


Public lists: Pharma Startups (6570)

Altea Therapeutics is using advanced delivery across the skin that aim to improve the efficacy, safety and compliance of drugs and vaccines.

Altea Therapeutics is using advanced delivery across the skin that aim to improve the efficacy, safety and compliance of drugs and vaccines.

Company (Alive / Active)

Phone: 404-835-6310

Fax:

387 Technology Circle NW
Suite 100
Atlanta, 30013
Georgia, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Altea Therapeutics $47M Jul 18, 2005
See all 17 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Altea Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 8 investors

Competitors

Company Status Description Investors

MacuSight

Palo Alto, California, United States
Alive / ActiveMacuSight is a privately-held pharmaceutical company focused on developing innovative therapeutics for the treatment of severe ocular diseases and conditions. The company is dedicated to preserving patients' vision by identifying known, highly-potent and broad-acting small molecule drug compounds that may possess efficacy in treating and/or preventing diseases or conditions of the eye. As part of its unique product development philosophy, MacuSight also concentrates on the optimal delivery of th...Show allLogin to see details

Santarus

San Diego, California, United States
AcquiredSantarus is a specialty pharmaceutical company focused on acquiring, developing and commercializing products for the prevention and treatment of gastrointestinal diseases and disorders. The company's primary business strategy is to develop and market proprietary products with new formulations, enhanced delivery systems or expanded indications that are based on currently marketed products or compounds that have clinically demonstrated safety and efficacy.Login to see details
See all 17 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Transdermal porator and patch system and method for using same Jan 22, 2008 Feb 14, 2012 Patent
Method for transdermal delivery of permeant substances Oct 24, 2003 Sep 13, 2011 Patent
Microporation of tissue for delivery of bioactive agents Feb 06, 2004 Jul 20, 2010 Patent
Disposable microporation porator Jul 24, 2008 Dec 08, 2009 Patent